We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 2,667 results
  1. Toxicological effect of acetaminophen, metamizole, and nimesulide cocktail on early development of zebrafish

    Background

    Several countries’ most incorrectly discarded medicines are acetaminophen (ACM), metamizole (MTZ), and nimesulide (NMS). These xenobiotics...

    Wellington Fernandes de Carvalho, Ednalva de Souza Pereira Lima, ... Hélio Batista Santos in DARU Journal of Pharmaceutical Sciences
    Article 11 July 2024
  2. The podoplanin-CLEC-2 interaction promotes platelet-mediated melanoma pulmonary metastasis

    Background

    Podoplanin (PDPN) expressed on tumour cells interacts with platelet C-type lectin-like receptor 2 (CLEC-2). This study aimed to investigate...

    Minjia Sheng, Ran Sun, ... Gao Lu in BMC Cancer
    Article Open access 01 April 2024
  3. Map** the single cell spatial immune landscapes of the melanoma microenvironment

    Melanoma is a highly immunogenic malignancy with an elevated mutational burden, diffuse lymphocytic infiltration, and one of the highest response...

    Jamie Magrill, Dan Moldoveanu, ... Ian R Watson in Clinical & Experimental Metastasis
    Article Open access 13 January 2024
  4. Augmenting MEK inhibitor efficacy in BRAF wild-type melanoma: synergistic effects of disulfiram combination therapy

    Background

    MEK inhibitors (MEKi) were shown to be clinically insufficiently effective in patients suffering from BRAF wild-type (BRAF WT) melanoma,...

    Francisco Meraz-Torres, Heike Niessner, ... Tobias Sinnberg in Journal of Experimental & Clinical Cancer Research
    Article Open access 23 January 2024
  5. Long non-coding RNA CCHE1 modulates LDHA-mediated glycolysis and confers chemoresistance to melanoma cells

    Melanoma is considered as the most common metastatic skin cancer with increasing incidence and high mortality globally. The vital roles of long...

    Zhi Ding, Junyi Yang, ... Fanli Guo in Cancer & Metabolism
    Article Open access 21 July 2023
  6. Sirtuin 5-mediated deacetylation of TAZ at K54 promotes melanoma development

    Purpose

    Nuclear accumulation of YAP/TAZ promotes tumorigenesis in several cancers, including melanoma. Although the mechanisms underlying the nuclear...

    Garam Kim, Poshan Yugal Bhattarai, ... Hong Seok Choi in Cellular Oncology
    Article 19 December 2023
  7. Breaking NGF–TrkA immunosuppression in melanoma sensitizes immunotherapy for durable memory T cell protection

    Melanoma cells, deriving from neuroectodermal melanocytes, may exploit the nervous system’s immune privilege for growth. Here we show that nerve...

    Tao Yin, Guo** Wang, ... Qi-**g Li in Nature Immunology
    Article 09 January 2024
  8. Identification and characterization of a new potent inhibitor targeting CtBP1/BARS in melanoma cells

    Background

    The C-terminal-binding protein 1/brefeldin A ADP-ribosylation substrate (CtBP1/BARS) acts both as an oncogenic transcriptional co-repressor...

    Angela Filograna, Stefano De Tito, ... Carmen Valente in Journal of Experimental & Clinical Cancer Research
    Article Open access 06 May 2024
  9. Immunotherapy in Melanoma and Merkel Cell Cancer

    Malignant melanoma is one of the most aggressive and lethal forms of skin cancer, with incidence rates continuing to rise due to increased sun...
    Melissa Chow, Elizabeth A. Sangalang, ... Adil I. Daud in Cancer Metastasis Through the Lymphovascular System
    Chapter 2022
  10. Novel cellular systems unveil mucosal melanoma initiating cells and a role for PI3K/Akt/mTOR pathway in mucosal melanoma fitness

    Background

    Mucosal Melanomas (MM) are highly aggressive neoplasms arising from mucosal melanocytes. Current treatments offer a limited survival...

    Matilde Monti, Luisa Benerini Gatta, ... William Vermi in Journal of Translational Medicine
    Article Open access 08 January 2024
  11. ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy

    Despite advancements in treating metastatic melanoma, many patients exhibit resistance to targeted therapies. Our study focuses on ATP1A1, a sodium...

    Laura Soumoy, Aline Genbauffe, ... Fabrice Journe in Cancer Cell International
    Article Open access 04 January 2024
  12. Epigenetically regulated PCDHB15 impairs aggressiveness of metastatic melanoma cells

    The protocadherin proteins are cell adhesion molecules at the crossroad of signaling pathways playing a major role in neuronal development. It is now...

    Arnaud Carrier, Cécile Desjobert, ... Joëlle Riond in Clinical Epigenetics
    Article Open access 28 November 2022
  13. The therapeutically actionable long non-coding RNA ‘T-RECS’ is essential to cancer cells’ survival in NRAS/MAPK-driven melanoma

    Finding effective therapeutic targets to treat NRAS-mutated melanoma remains a challenge. Long non-coding RNAs (lncRNAs) recently emerged as...

    Valentin Feichtenschlager, Linan Chen, ... Susana Ortiz-Urda in Molecular Cancer
    Article Open access 22 February 2024
  14. Plectin promotes tumor formation by B16 mouse melanoma cells via regulation of Rous sarcoma oncogene activity

    Background

    Melanoma is a malignant tumor characterized by high proliferation and aggressive metastasis. To address the molecular mechanisms of the...

    Kana Mizuta, Takuma Matsubara, ... Shoichiro Kokabu in BMC Cancer
    Article Open access 30 August 2022
  15. Potential clinical implications of CD4+CD26high T cells for nivolumab treated melanoma patients

    Background

    Nivolumab is an anti-PD1 antibody that has dramatically improved metastatic melanoma patients’ outcomes. Nevertheless, many patients are...

    Domenico Galati, Serena Zanotta, ... Paolo A. Ascierto in Journal of Translational Medicine
    Article Open access 11 May 2023
  16. Hyaluronic acid-antigens conjugates trigger potent immune response in both prophylactic and therapeutic immunization in a melanoma model

    Immunotherapy of advanced melanoma has encountered significant hurdles in terms of clinical efficacy. Here, we designed a clinically translatable...

    Alessio Malfanti, Mathilde Bausart, ... Véronique Préat in Drug Delivery and Translational Research
    Article 11 April 2023
  17. A novel cocktail therapy based on quintuplet combination of oncolytic herpes simplex virus-2 vectors armed with interleukin-12, interleukin-15, GM-CSF, PD1v, and IL-7 × CCL19 results in enhanced antitumor efficacy

    Background

    Selectively replicating herpes simplex virus-2 (HSV-2) vector is a promising treatment for cancer therapy. The insertion of multiple...

    Han Hu, Siqi Zhang, ... Binlei Liu in Virology Journal
    Article Open access 22 April 2022
  18. Circulating tumor cells from melanoma patients show phenotypic plasticity and metastatic potential in xenograft NOD.CB17 mice

    Background

    Innovative therapies have improved the overall survival in melanoma, although a high number of patients still experience disease...

    Claudia Felici, Francesco Mannavola, ... Marco Tucci in BMC Cancer
    Article Open access 11 July 2022
  19. The cure from within? a review of the microbiome and diet in melanoma

    Therapy for cutaneous melanoma, the deadliest of the skin cancers, is inextricably linked to the immune system. Once thought impossible, cures for...

    Priyanka Kumar, Danielle Brazel, ... Justin T. Moyers in Cancer and Metastasis Reviews
    Article Open access 27 April 2022
  20. FGF-trap** hampers cancer stem-like cells in uveal melanoma

    Background

    Cancer stem-like cells (CSCs) are a subpopulation of tumor cells responsible for tumor initiation, metastasis, chemoresistance, and...

    Alessandra Loda, Stefano Calza, ... Sara Rezzola in Cancer Cell International
    Article Open access 11 May 2023
Did you find what you were looking for? Share feedback.